Nicox on SPi NewsFollow our SPi News RSS Feed for nicox

Featured nicox News

[02 May 2019] Nicox: Number of voting rights 30 April 2019

[29 Apr 2019] Nicox to Present at Upcoming Pharmaceutical Industry and Financial Events

[24 Apr 2019] Nicox: Number of voting rights as of 24 April 2019

[18 Apr 2019] Nicox First Quarter 2019 Business Update and Financial Highlights

[19 Mar 2019] Nicox Initiates Phase 2 Trial of NCX 4251 in Blepharitis

[06 Mar 2019] Nicox Announces 2018 Financial Results and 2019 Milestones

[04 Jan 2019] VYZULTA Approved in Canada by Nicox's Partner

[30 Oct 2018] Nicox Postpones NASDAQ Listing Due to Market Volatility

[17 Oct 2018] Nicox Third Quarter 2018 Business Update and Financial Highlights

[06 Sep 2018] Nicox First Half 2018 Financial Results and Business Update

[06 Sep 2018] Nicox First Half 2018 Financial Results and Business Update

[17 Jul 2018] Nicox Second Quarter 2018 Business Update and Financial Highlights

[29 Jun 2018] Nicox Highlights Recent Progress with Key Programs and Activities

[04 May 2018] Nicox Provides First Quarter 2018 Business and Financial Results

[03 May 2018] Nicox announces the presentation of scientific data for NCX 667 at ARVO 2018

[06 Mar 2018] Nicox provides 2018 Outlook and 2017 Estimated Financial Results

[03 Jan 2018] Nicox Appoints Tomas Navratil, Ph.D., as Head of Development

[08 Sep 2017] Nicox first half 2017 business and financial update

[31 May 2017] Nicox receives FDA approval of ZERVIATE1 (cetirizine ophthalmic solution) 0.24%

[09 Mar 2017] Nicox resubmits AC-170 (ZERVIATE) NDA to the U.S. FDA

[01 Mar 2017] Nicox to participate at two upcoming investor conferences

[21 Feb 2017] Nicox announces the presentation of NCX 667 scientific data at AOPT 2017

[21 Feb 2017] Nicox announces the presentation of NCX 667 scientific data at AOPT 2017

[24 Jan 2017] Nicox provides clinical and regulatory update for NCX 470 for IOP lowering

[05 Jan 2017] Nicox provides clinical and regulatory update for NCX 4251 in blepharitis

[10 Nov 2016] Nicox to present at the Stifel 2016 Healthcare Conference

[09 Nov 2016] Nicox Provides Update on Latanoprostene bunod and AC-170

[11 Oct 2016] Nicox third quarter 2016 business update and cash position

[10 Oct 2016] Nicox Receives Complete Response Letter from the FDA Related to GMP on NDA for AC-170

[22 Sep 2016] Nicox first half 2016 business and financial update

[27 Jun 2016] Nicox added to Russell Global Index

[21 Jun 2016] U.S. FDA grants Priority Review for Nicox's AC-170 New Drug Application

[10 May 2016] Nicox first quarter 2016 financial and business update

[09 May 2016] Nicox announces the presentation of scientific data at ARVO 2016

[19 Apr 2016] Nicox submits New Drug Application for AC-170 to U.S. FDA

[15 Apr 2016] Nicox: 2015 Financial Results and Business Update

[06 Apr 2016] Nicox to present at the 15th Annual Needham Healthcare Conference

[03 Feb 2016] Nicox to present at the 18th Annual BIO CEO & Investor Conference

[29 Jan 2016] Nicox out-licenses OTC asset AC 120 to Ora, Inc.

[28 Aug 2015] Nicox first half 2015 highlights

[24 Jul 2015] NICOX : Bausch + Lomb confirms submission of Vesneo(TM) NDA to US FDA

[17 Nov 2014] Acquisition of Nicox's US ophthalmic diagnostics subsidiary by Valeant

[30 Oct 2014] Nicox announces third quarter 2014 financial update

[27 Oct 2014] Nicox completes the acquisition of Aciex Therapeutics, Inc.

[10 Oct 2014] Nicox: Publication of shareholder presentation of October 10, 2014

[16 Sep 2014] Nicox acquires Carragelose(R) anti-viral eye drop program

[28 Aug 2014] Nicox first half 2014 financial results

[11 Aug 2014] Nicox announces changes to its Board of Directors

[02 Jul 2014] Nicox to acquire Aciex Therapeutics, Inc.

[30 Jun 2014] Nicox launches commercial operations in Germany


Still looking?

Type in your search term below and click Enter

World News from SPi

Sector Publishing Intelligence [SPi'] publishes financial news from around the world FAST. For breaking news announcements from companies, blogs and commentators, SPi provides up to the minute, integrated news on all aspects of financial markets and financial services.

The SPi Financial News Search gets results from our extensive news archives containing 10’s of thousands of news reports. Intelligent cross referencing of stories and background gives readers and researchers highly relevant related information about topics and businesses in the finance sector.

Trending financial topics highlight the most recent themes in the news. Thousands of financial topics can be followed using RSS, or join hundreds of SPis Financial News followers on Twitter for instant news as soon as it’s published on SPi. @SPiFinancialSvc

SPi's extensive database of corporate information shows company details alongside breaking corporate news from the world’s largest news providers.

SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2019. [Admin Only]
 
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 07519380.
 
Privacy Policy | Terms and Conditions | Contact Us